Natural Capital Research
PrivateLast Round
Series A
Jul 3, 2024
Total Funding Raised
$13.11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Natural Capital Research operates in Energy & Sustainability and is based in London. Its latest recorded funding round was a Series A round in July 2024.
Natural Capital Research is an environmental technology company that offers a nature and biodiversity intelligence platform designed to measure, enhance, report, and value natural capital while integrating advanced scientific methods, machine learning, and remote sensing to support a nature-positive transition in business practices.
Sector
Energy & Sustainability
Verticals
ESG Analytics, Compliance & Risk, Environmental Monitoring, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Natural Capital Research Comparables
Compare Natural Capital Research with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NatureAlpha | 86% | |
| Nala Earth | 84% | |
| refinq | 81% |
For institutional investors. Book with your work email.
Natural Capital Research Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 3, 2024 | ||||
| Seed | Feb 6, 2023 | ||||
| Seed | Jul 5, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Natural Capital Research Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pelican Ag | Series A |
| Oxford Science Enterprises | Seed, Series A |
| Norinchukin Capital Co., Ltd. | Series A |
| Norinchukin Capital | Series A |
| MW&L Capital Partners | Seed, Series A |
| Yeo Ventures | Series A |
| Schroders | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 61% MoM, reaching 2.1K.
- Mar 29, 2026
Launched Agricultural Commodity Tracing Tool with sub-national data capabilities.
For institutional investors. Book with your work email.
Natural Capital Research Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Natural Capital Research's valuation, stock price, and market status.
Is Natural Capital Research a public or private company?
Natural Capital Research is a private company.
What is the current stock price of Natural Capital Research?
Natural Capital Research is a private company, so its shares have no public market price. Caplight tracks Natural Capital Research's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Natural Capital Research worth (valuation)?
Valuation information for Natural Capital Research is not publicly available.
Can I buy Natural Capital Research stock?
Natural Capital Research shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Natural Capital Research's last funding round?
Natural Capital Research's most recent funding round was Series A on July 3, 2024.
Who are the main investors in Natural Capital Research?
Key investors in Natural Capital Research include Oxford Science Enterprises, Schroders.
Will Natural Capital Research IPO soon?
No public IPO plans have been announced for Natural Capital Research.
How can I track Natural Capital Research secondary market activity?
Caplight tracks bids, offers, and trades in Natural Capital Research's shares on secondary markets.